Stock CTV INNOVID CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Innovid Corp.

Equities

CTV

US4576791085

End-of-day quote Nyse
Other stock markets
 03:30:00 03/05/2024 am IST 		5-day change 1st Jan Change
2.32 USD +2.65% Intraday chart for Innovid Corp. +12.62% +54.67%
08/05 Needham Adjusts Price Target on Innovid to $3 From $2.25, Maintains Buy Rating MT
07/05 Transcript : Innovid Corp., Q1 2024 Earnings Call, May 07, 2024

Evolution of the average Target Price on Innovid Corp.

Price target over the last 5 years

History of analyst recommendation changes

fc0a3463d83bad7ff99441c4.91a7oWih44DsP_YnP7IUehay3EKQLDRkXKyk8NkJS7Y.wGKK9xj0mbSNVqZzeNNDC2XarADFf0USA9v8uu1hKenHPfT5JtG21I9okQ~adb193d9d1e70e8a04add548ce57deb7

Analyst Recommendations on Innovid Corp.

Needham Adjusts Price Target on Innovid to $3 From $2.25, Maintains Buy Rating MT
Needham Adjusts Price Target on Innovid to $2.25 From $1.50, Maintains Buy Rating MT
Morgan Stanley Adjusts Innovid's Price Target to $1.50 From $1.40, Maintains Equalweight Rating MT
Needham Cuts Price Target on Innovid to $1.50 From $3, Keeps Buy Rating MT
Morgan Stanley Adjusts Innovid's Price Target to $1.40 From $1.10, Keeps Equalweight Rating MT
Morgan Stanley Adjusts Price Target on Innovid to $1.10 From $2.20, Maintains Equal-Weight Rating MT
Morgan Stanley Adjusts Innovid's Price Target to $2.20 From $2.40, Maintains Equal Wright Rating MT
JMP Securities Adjusts Price Target on Innovid to $5 From $6, Maintains Market Outperform Rating MT
Needham Adjusts Price Target on Innovid to $3 From $4, Maintains Buy Rating MT
Innovid Shares Plunge After Morgan Stanley Initiates Coverage MT
Morgan Stanley Initiates Innovid at Underweight with $2.70 Price Target MT
Morgan Stanley Starts Innovid at Underweight with $2.70 Price Target MT
JMP Securities Trims Innovid's Price Target to $6 From $9, Keeps Market Outperform Rating MT
Needham Adjusts Innovid's Price Target to $6 from $10, Maintains Buy Rating MT
BMO Capital Adjusts Innovid's Price Target to $8 from $13, Maintains Outperform Rating MT
JMP Securities Starts Innovid at Market Outperform With $11 Price Target MT
Needham Starts Innovid at Buy With $10 Price Target MT
BMO Capital Starts Innovid at Outperform With $13 Price Target MT
Evercore ISI Starts Innovid at Outperform With $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.94 USD
Average target price
2.733 USD
Spread / Average Target
+40.89%
High Price Target
3 USD
Spread / Highest target
+54.64%
Low Price Target
2.2 USD
Spread / Lowest Target
+13.40%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Innovid Corp.

Needham & Co.
Morgan Stanley
JMP Securities
BMO Capital
Evercore ISI

Ratings for Innovid Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CTV Stock
  4. Consensus Innovid Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW